Jan Hontelez
Jan Hontelez
Erasmus MC
Geverifieerd e-mailadres voor erasmusmc.nl
Geciteerd door
Geciteerd door
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ...
PLoS Med 9 (7), e1001245, 2012
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
HIV and aging--preparing for the challenges ahead
MD Till Bärnighausen, JN MIA
The New England journal of medicine 366 (14), 1270, 2012
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
AIDS (London, England) 26 (0 1), 2012
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS Med 10 (10), e1001534, 2013
Ageing with HIV in south africa
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
AIDS (London, England) 25 (13), 2011
Postoperative cognitive dysfunction in geriatric patients
KA Hartholt, TJM van der Cammen, M Klimek
Zeitschrift für Gerontologie und Geriatrie 45 (5), 411-416, 2012
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Med 9 (7), e1001259, 2012
Costs, effects and cost‐effectiveness of breast cancer control in Ghana
SG Zelle, KM Nyarko, WK Bosu, M Aikins, LM Niëns, JA Lauer, ...
Tropical Medicine & International Health 17 (8), 1031-1043, 2012
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness
R Baltussen, MP Jansen, E Mikkelsen, N Tromp, J Hontelez, L Bijlmakers, ...
International journal of health policy and management 5 (11), 615, 2016
Time and money: the true costs of health care utilization for patients receiving ‘free’HIV/TB care and treatment in rural KwaZulu-Natal
N Chimbindi, J Bor, ML Newell, F Tanser, R Baltusen, J Hontelez, ...
Journal of acquired immune deficiency syndromes (1999) 70 (2), e52, 2015
Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral …
JW Eaton, N Bacaër, A Bershteyn, V Cambiano, A Cori, RE Dorrington, ...
The Lancet Global Health 3 (10), e598-e608, 2015
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
Balancing efficiency, equity and feasibility of HIV treatment in South Africa–development of programmatic guidance
R Baltussen, E Mikkelsen, N Tromp, AK Hurtig, J Byskov, Ø Olsen, ...
Cost Effectiveness and Resource Allocation 11 (1), 1-9, 2013
Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia?
R Steen, JAC Hontelez, A Veraart, RG White, SJ de Vlas
Aids 28 (6), 891-899, 2014
The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model
JAC Hontelez, N Nagelkerke, T Bärnighausen, R Bakker, F Tanser, ...
Vaccine 29 (36), 6100-6106, 2011
Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study
R Atun, AY Chang, O Ogbuoji, S Silva, S Resch, J Hontelez, ...
BMJ open 6 (3), 2016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20